Ajanta Pharma Latest News

  1. Pursuant to Regulation 47 of the Listing Regulations, Ajanta Pharma has informed that the meeting of Board of Directors of the Company to be held on Wednesday, 5th February 2020 published in the newspapers, The Free Press Journ...

    Date:21-01-2020
  2. Total consolidated income of the company increased by 17.28% at Rs 655.98 crore for Q2FY20
    Date:06-11-2019
  3. Total consolidated income of the company increased by 17.28% at Rs 655.98 crore for Q2FY20
    Date:06-11-2019
  4. As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has confirmed that activities in relation to both physical and electronic shar...

    Date:11-10-2019
  5. Ajanta Pharma has informed about issue of Duplicate Share Certificates under Regulation 39(3) of SEBI (LODR) Regulations, 2015.

    The above information is a part of company’s fi...

    Date:13-08-2019
  6. Ajanta Pharma has informed about submission of certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018. 

    The above information is a part of company’s filings submitted to BSE....

    Date:24-07-2019
  7. Ajanta Pharma has informed about loss of shares certificate.

    The above information is a part of company’s filings submitted to BSE.

    ...
    Date:27-06-2019
  8. Ajanta Pharma has informed about submission of Annual Report for financial year 2018-19 under Regulation 34(1). 

    The above information is a part of company’s filings submitted to BSE.

    ...
    Date:20-06-2019
  9. The company has reported a fall of 47.30% in its standalone net profit for the quarter ended March 31, 2019
    Date:03-05-2019
  10. Ajanta Pharma has informed that the Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aayush Agrawal Trust.&l...

    Date:16-04-2019
Return to Top
Puchho Befikar